Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857090 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones
A Phase 1 study, sponsored by Omeros Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00857090 is a Phase 1 study that has completed, run by Omeros Corporation. The registered enrollment target is 18 participants.
The verdict
NCT00857090, a Phase 1 study, has completed, sponsored by Omeros Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objectives of the study are to assess the systemic exposure, safety and efficacy of three concentrations of OMS201 in subjects undergoing retrograde ureteroscopic removal of upper urinary tract stones.
Interventions
- DRUG Vehicle
- DRUG OMS201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00857090
The ClinicalTrials.gov registry entry for NCT00857090 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeros Corporation, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT00857090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00857090 about?
NCT00857090 is a clinical study titled "Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones". The objectives of the study are to assess the systemic exposure, safety and efficacy of three concentrations of OMS201 in subjects undergoing retrograde ureteroscopic removal of upper urinary tract stones.
What is the current status of trial NCT00857090?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2009-03. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00857090?
The interventions under investigation include: Vehicle (DRUG), OMS201 (DRUG).
Who is sponsoring clinical trial NCT00857090?
This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.